ライフサイエンスコーパス: convalescent-phase sera

1 c IgM or IgG antibody titers from acute- and convalescent-phase sera.

2 body titers between collection of acute- and convalescent-phase sera.

3 he carboxyl-terminal half of IpaD with a few convalescent-phase sera.

4 on of 2009 H1N1 virus-specific antibodies in convalescent-phase sera.

5 In conclusion, we show high sensitivity in convalescent-phase sera and high specificity for the Abb

6 d aa 1 to 213 reacted specifically with SARS convalescent-phase sera but not with negative human sera

7 ole or fractionated bacterial proteomes with convalescent-phase sera can potentially accelerate ident

8 pneumonic plague models, passive transfer of convalescent-phase sera confers protection, as does acti

9 d rise in antibody titer from acute-phase to convalescent-phase sera for LukAB, the most recently des

10 By using convalescent-phase sera from 10 Shigella flexneri-infect

11 Convalescent-phase sera from 33 of 44 patients in the PS

12 epitope were highly reactive with all of the convalescent-phase sera from 40 SARS patients but not wi

13 The recombinant proteins reacted with convalescent-phase sera from dogs and human patients rec

14 In this study, we investigated convalescent-phase sera from H7N7-exposed individuals by

15 Convalescent-phase sera from NV-infected individuals sho

16 ), respectively, by Pepscan analyses against convalescent-phase sera from SARS patients and antisera

17 ts with seven different sera, including five convalescent-phase sera from these patients, one dog ant

18 Convalescent-phase sera from these primed mice conferred

19 mmunosorbent assays (ELISAs) with human HCMV-convalescent-phase sera from unselected donors confirmed

20 dian = 6.0) after the onset of symptoms, and convalescent-phase sera (n = 128) were collected >or=15

21 of human sera, including group C and group B convalescent-phase sera, normal sera with naturally occu

22 detection of babesial antibody in acute-and convalescent-phase sera, or identification of the organi

23 Analysis of convalescent-phase sera showed high titers of GP38 antib

24 rediction model were significantly higher in convalescent-phase sera than in paired acute-phase sera.

25 gic study was conducted on stored acute- and convalescent-phase sera that had been submitted for Rock

26 pment of serological criteria for evaluating convalescent-phase sera that optimize detection of true

27 When used to examine convalescent-phase sera, the IFA is positive in 93% of b

28 capsid and reacted with pig hyperimmune and convalescent-phase sera to PEC Cowden in enzyme-linked i

29 The sensitivity for convalescent-phase sera was 93.8% by MAT, 84.4% by DST,

30 In this study, acute- and convalescent-phase sera were evaluated against different

31 erved in 21 of 23 patients (91.3%) from whom convalescent-phase sera were obtained.